←Back to Expert Scholars
Translational Medicine / 转化医学AML Novel Targets, Leukemia Trials
Hagop Kantarjian
MD
🏢MD Anderson Cancer Center🌐USA
Chair, Department of Leukemia
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Hagop Kantarjian chairs Leukemia at MD Anderson and is one of the most prolific leukemia clinical trialists worldwide. He has led many pivotal AML and ALL drug development programs. His career has shaped standards for multiple leukemia subtypes.
Share:
🧪Research Fields 研究领域
AML novel agents
CML
ALL trials
leukemia drug development
MD Anderson leukemia
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Hagop Kantarjian 的研究动态
Follow Hagop Kantarjian's research updates
留下邮箱，当我们发布与 Hagop Kantarjian（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment